A few days ago, atotal of 260 enterprises ranked first in the 2019 TOP100 list of China's pharmaceutical industry released by domestic medical industry authority menet and medical economics daily, and were included in five sub-lists, including "TOP100 Chinese pharmaceutical enterprises" and "TOP100 Chinese traditional medicine enterprises". Among them,DoubleMedical once again ranked the TOP20 of Chinese medical device (including IVD) enterprises in 2019 again.

This selection focuses on the innovation driving force and professional promotion power of pharmaceutical industry enterprises. The innovation driving force is mainly judged from the comprehensive index of R&D investment of enterprises, the professional promotion power focuses on the rigid definition of terminal quantitative data determined by the final selection needs of clinicians and patients, and finally carries out quantitative analysis based on the exclusive data of three terminals and six market terminals of menet .After 16 years of development and outstanding comprehensive strength, DoubleMedical has been widely recognized and praised both inside and outside the industry.

Strength is prominent.

The first orthopedic medical device company listed in A-share.

DoubleMedical, founded in 2004, specializes in the research, development, production and sales of medical high-value materials, and is the first orthopedic medical device company listed in A-share (stock code 002901).

In 2019, DoubleMedical achieved sales revenue of 1.26 billion yuan and tax payment of 200 million yuan. It is one of the only two enterprises in China with sales revenue of orthopaedic products exceeding 1 billion yuan and tax payment exceeding 200 million yuan.

High speed development.

To become a leading enterprise in the field of orthopedic implant medical consumables.

As one of the leading enterprises in the field of orthopedic implant medical consumables, DoubleMedical orthopedic trauma implant consumables ranks first among domestic brands in market share, and third among domestic brands in market share of orthopedic spine implant consumables.

In the domestic market, DoubleMedical products cover more than 4,000 hospitals in China, including more than 1,000 third-grade class-A hospitals, accounting for more than 70% of the national third-grade class-A hospitals.

In the international market,DoubleMedical products are exported to Europe and the United States, Africa, the Middle East, South America and other parts of the world. Over the years, the sales volume has been growing steadily. From 2016 to 2019,DoubleMedical products have been exported to the first place in the orthopaedic industry for four consecutive years.

In 2019, there were more than 500,000 surgical implants for DoubleMedical productsat homeand abroad.

A good momentum.

It can reach the international first-class enterprise level within five years.

In recent years, DoubleMedical advantage prominent, a good momentum of development, especially in new product development, new business and new market development has made great progress, the brand influence, brand value is also significantly increased, is expected to reach the international first-class enterprise level in five years,become a national leading brand that can compete with multinational giants.

Product technology leading.

DoubleMedical clinical application oriented, on the basis of a strong r&d team, combining the majority of clinical experts wisdom, and constantly introduce innovative is strong, advanced technology products, has 227 patents, innovative research and development leading orthopaedic enterprises in China, especially in the field of orthopaedic trauma, spine products has become a measure of other domestic enterprises are pursued, imitate.

The quality is reliable.

DoubleMedical strictly implements the international quality standards including ISO13485, GMP and ISO9001, and its products have passed a series of international certifications such as FDA, CE, Korean MFDS and Gulf GCC.

The products have been tested and verified scientifically, and the quality parameters surpass those of international famous brands.

In 2019, there were more than 500,000 surgical implants at home and abroad, and no quality-related adverse events occurred.

Full product line coverage.

DoubleMedical is one of the few domestic enterprises that have achieved the full product line coverage in the fields of trauma nail system, intramedullary nail system, ankle system, pediatric orthopedics, external fixation scaffold, spinal system, joint system, sports medicine, etc.

It has 69 registration certificates of third-class medical devices, 23 registration certificates of second-class medical devices and 231 record certificates of first-class medical devices.

High degree of internationalization.

At present, DoubleMedical products are exported to more than 50 countries and regions such as Australia, Russia, Spain, etc. For four consecutive years, its export volume ranks the first in the domestic orthopedics industry, and it is the only domestic enterprise whose annual export volume exceeds $10 million.

DoubleMedical established a good R&D cooperation with internationally renowned experts from Australia, Russia, Switzerland and Germany.